Active Ingredient(s): Acetohydroxamic Acid
FDA Approved: * May 31, 1983
Pharm Company: * MISSION PHARMA
Category: Urinary System

Acetohydroxamic acid (also known as AHA or by the trade name Lithostat) is a drug that is a potent and irreversible enzyme inhibitor of the urease enzyme in various bacteria and plants; it is usually used for urinary tract infections. The molecule is similar to urea but is not hydrolyzable by urease;[1] it thus disrupts the bacteria's metabolism through competitive inhibition. Orphan drug In 1983 the US Food and Drug Administration approved acetohydroxamic acid (AHA) as an ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lithostat MPC;500
Lithostat 250 mg Oral Tablet
NDC: 0178-0500
Mission Pharmacal Company